Melissa Sherman (@mobilion_ceo) 's Twitter Profile
Melissa Sherman

@mobilion_ceo

MOBILion CEO, storyteller for the best team ever.

ID: 1454442653953765376

calendar_today30-10-2021 13:38:58

225 Tweet

358 Takipçi

747 Takip Edilen

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Pioneering discoveries start with precision. See how top scientists are using the MOBIE system to accelerate research—from cutting run times by 95% to achieving separations that were once impossible. Download the eBook and push the boundaries of science: view-su2.highspot.com/viewer/9ce1f3e…

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

We’re excited to join the 73rd ASMS Conference this June! Our team and collaborators will showcase over 30 presentations and posters on advancing separation science, PAMAF, and applications in proteomics, metabolomics, and analytical chemistry. See you there! #ASMS2025

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Merck’s results with the MOBIE system speak for themselves—72% faster analysis and 200% greater resolving power for peptide soft spots. How many are you missing? Learn how MOBIE is redefining cyclic peptide drug development. #MassSpec #DrugDiscovery

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Earth Day is around the corner—are we doing enough to protect our planet? Non-targeted analysis (NTA) is revolutionizing environmental monitoring, uncovering hidden contaminants. MOBIE is leading the charge! This is a must-read. #NTA #PFAS #EarthDay U.S. EPA

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

PAMAF is a game-changer. Proud to see our CTO Daniel DeBord share how it tackles ion utilization head-on—transforming omics workflows and pushing the boundaries of what's possible in MS. 25 years of innovation, and we're just getting started. #massspec #ionmobility

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Excited to see our partner Prof. Dr. Oliver Schmitz present groundbreaking research on next-gen ion mobility MS at #analytica Vietnam! Don’t miss his talk on April 3rd at 15:10 as he dives into CTIMS vs. SLIM using complex lipidome samples. #massspec #ionmobility

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

We're proud to support groundbreaking work like this. Dr. Yates’ insights and the power of DeGlyPHER + PAMAF show how smart science and smart tech come together to drive vaccine innovation forward. Don’t miss it! #biotech #glycomics #vaccineResearch

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Excited to showcase how #PAMAF is redefining analytical performance at #ASMS2025. Join us at booth #434 to see how high-resolution ion mobility is shaping the future of separation science. Let’s push the boundaries—together. Am Soc for Mass Spec

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

I had a great conversation with BioTuesdays about how our PAMAF technology is redefining fragmentation analysis—5× faster throughput, near 100% ion utilization, and precision like never before. If you missed it, catch the interview here: biotuesdays.com/2025/02/04/mob…

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

We’re thrilled to see our strategic partner, Dr. Erin Baker, taking the stage as the plenary speaker at the 6th Annual Canadian Metabolomics Conf. next week. Her work continues to push the boundaries of what’s possible in lipidomics and chemical exposure analysis. Don’t miss it!

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

As CEO, I’m proud of our team’s work shining a light on PFAS this Earth Day. Our tech helps uncover what others can’t see—empowering scientists to protect people and the planet. Because insight drives impact. Read more: view-su2.highspot.com/viewer/64ca953… #EarthDay #PFAS #science

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Excited to share that our popular ASMS breakfast seminars are back! Start your mornings with bold insights, strong coffee, and fresh connections. Space is limited, so register here: go.mobilionsystems.com/ASMS2025_Break… #ASMS2025 #MassSpec

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Proud to kick off #ASMS2025 with brilliant partners showcasing real-world impact of MOBIE! From PFAS to peptides, it’s exciting to see our tech in action. Don’t miss the Monday breakfast seminar—room 321, 7AM!

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Don’t miss our Tuesday, June 3rd breakfast seminar at #ASMS2025! Two powerhouse speakers—Dr. Birgit Schilling & Dr. Benjamin Orsburn—plus a deep dive into our game-changing PAMAF tech. It’s all happening 7–8:15am ET in Room 321. See you there! Am Soc for Mass Spec

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Looking forward to kicking off ASMS with critical insights on PFAS from Dr. Sarah Choyke of Eurofins. Spaces are going fast—don’t miss the chance to hear how MOBIE is redefining PFAS analysis. Register here: go.mobilionsystems.com/ASMS2025_Break… Am Soc for Mass Spec #asms2025 #MOBIE #PFAS

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Here is an overview of our upcoming ASMS 2025 conf. pres. & activities. Find us at Booth 434. Over 40 pres. from customers & collaborators: 🔥 Highlighting the MOBIE product, and 🚀 An early preview of our future BILLIE proteomics platform lnkd.in/eVXs6wfk Am Soc for Mass Spec

Melissa Sherman (@mobilion_ceo) 's Twitter Profile Photo

Excited for Andrew Feilden’s upcoming breakfast seminar at ASMS. The work being done by Bicycle Therapeutics in peptide therapeutics is truly groundbreaking—and it’s even more rewarding to see how our MOBIE system played a key role in their success. Don’t miss this one! Am Soc for Mass Spec